Clinical Trials Logo
  1. Home
  2. Induced; Birth
  3. NCT05037617

The REDUCED-I Pilot Trial: REDucing the Utilization of CEsarean Sections With Induction — (REDUCED-I)  

Induced; Birth Clinical Trial

Official title:
The REDUCED-I Pilot Trial: REDucing the Utilization of CEsarean Sections With Induction

Clinical Trial Summary

This pilot project is a randomized controlled trial where induced patients receive an intervention of oxytocin discontinuation once in the active stage of labor (≥6 cm dilation). The intent is to reduce uterine hyperstimulation and fetal distress, therefore, lowering cesarean sections (CS) in first time mothers at term (≥ 37 weeks), with a cephalic presenting singleton fetus, without increasing maternal or neonatal morbidity. If REDUCE-I pilot trial suggests a safe reduction in CS rates and patient satisfaction, application for a multi-centre randomized controlled trial would follow.

Clinical Trial Description

This pilot project is a randomized controlled trial of a proposed intervention to modify management of labor inductions once in the active first stage of labor. The intervention will take place at Foothills Medical Centre (FMC). Randomization will be computer generated, participants will be stratified by need for cervical ripening and randomization will be blocked. Participants will be primiparous women 18 years old or older, at term (≥ 37 weeks) with a cephalic presenting singelton fetus undergoing induction of labor with oxytocin. Once patients are in the active first stage of labor, study medication will be initiated (identical vials of oxytocin or saline prepared by the Alberta Health Services Research Pharmacy). Treatment period will continue until delivery. If the frequency of contractions are reduced to less than 2 in 10 minutes or there has been no change in dilation for 4 hours, then oxytocin can be restarted. Royal Alexandra Hospital in Edmonton will be used as a contemporaneous non-intervention control site. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05037617
Study type Interventional
Source University of Calgary
Contact
Status Completed
Phase N/A
Start date October 25, 2021
Completion date February 15, 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT03730220 - The Norwegian Induction Project: a Pilot for a Prospective National Audit
Completed NCT05100264 - Effect of Acidic Vaginal pH on the Efficacy of Dinoprostone for Labor Induction N/A
Recruiting NCT06272591 - Comparison of Patient Satisfaction With Home Induction and In-patient Induction.
Completed NCT03670836 - Comparison of Misoprostol Ripening Efficacy With Dilapan Phase 4
Completed NCT04017247 - Continuous Versus Intermittent Oxytocin Infusion for Induction of Labor N/A
Completed NCT05062343 - Cook Balloon vs Dilapan-S for Outpatient Cervical Ripening N/A
Completed NCT02788305 - Effect of Maternal Obesity on Labour Induction in Postdate Pregnancy N/A
Terminated NCT04004845 - Labor Protocol Study
Recruiting NCT06053073 - Induction to Labour With Double Cervical Ballon at Home Versus at Hospital N/A
Completed NCT04645823 - Spinal Fentanyl or Epidural Analgesia in the Early First Phase of Induced Labor Phase 4
Completed NCT04746248 - Outpatient Labor Induction Using Oral Misoprostol in Norway N/A
Recruiting NCT05671224 - Visual Aids for Induction of Labor RCT N/A
Completed NCT04756089 - Stimulation Therapy for Inducing Mothers N/A
Recruiting NCT05798728 - Outpatient Transcervical Balloon For Induction of Labor N/A
Withdrawn NCT04739683 - Cervical Ripening With Foley Bulb Versus Dilapan-S at Home N/A
Not yet recruiting NCT04307199 - Membrane Sweeping to Prevent Post-term Pregnancy: The MILO Study N/A
Completed NCT03725397 - Inpatient Versus Outpatient Foley Cervical Ripening Study N/A
Recruiting NCT05719467 - SAINT: Safe Induction of Labor Trial Phase 3
Completed NCT03113227 - Value of Measuring Cervical Angle and Length by Ultrasound in Prediction of Successful Induction of Delivery N/A